Phathom Pharmaceuticals Inc

NASDAQ:PHAT   3:59:39 PM EDT
33.76
-1.23 (-3.52%)
Earnings Announcements

Phathom Pharmaceuticals Reports Fourth Quarter And Full Year 2020 Financial Results

Published: 03/30/2021 20:31 GMT
Phathom Pharmaceuticals Inc (PHAT) - Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress.
Phathom Pharmaceuticals Inc - Qtrly Loss per Share $1.58.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.19

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.11

More details on our Analysts Page.